News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cambridge's SAGE Therapeutics Ups Proposed IPO Deal Size



7/17/2014 8:46:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Sage Therapeutics, which is developing treatments for life-threatening epileptic seizures, raised the proposed deal size for its upcoming IPO on Thursday. The Cambridge, MA-based company now plans to raise $88 million by offering 5 million shares at a price range of $17 to $18. The company had previously filed to offer 4 million shares at a range of $14 to $16.

At the midpoint of the revised range, Sage Therapeutics will raise 46% greater proceeds than previously anticipated at a market cap of $463 million, up 21% from its prior $382 million market cap.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq


comments powered by Disqus
Nasdaq
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES